公开(公告)号：US10011586B2

公开(公告)日：2018-07-03

申请号：US15556352

申请日：2016-06-07

Applicant: Daewoong Pharmaceutical Co., Ltd.

Inventor： Joon Seok Park ,  Youn Jung Yoon ,  Min Jae Cho ,  Ho Bin Lee ,  Ja Kyung Yoo ,  Bong Yong Lee

IPC: C07D401/06 ,  C07D417/14 ,  C07D401/14 ,  C07D471/04

CPC classification number: C07D401/06 ,  A61P35/00 ,  C07D401/14 ,  C07D417/14 ,  C07D471/04

Abstract: The present invention relates to a heterocyclic compound having a novel structure that can be used in the prevention or treatment of diseases caused by abnormality in a PRS (prolyl-tRNA synthetase) activity, a method for preparing the same, and a pharmaceutical composition comprising the same.

公开(公告)号：US20180044322A1

公开(公告)日：2018-02-15

申请号：US15556352

申请日：2016-06-07

Applicant: Daewoong Pharmaceutical Co., Ltd.

Inventor： Joon Seok Park ,  Youn Jung Yoon ,  Min Jae Cho ,  Ho Bin Lee ,  Ja Kyung Yoo ,  Bong Yong Lee

IPC: C07D401/06 ,  C07D417/14 ,  C07D401/14 ,  C07D471/04

CPC classification number: C07D401/06 ,  C07D401/14 ,  C07D417/14 ,  C07D471/04

Abstract: The present invention relates to a heterocyclic compound having a novel structure that can be used in the prevention or treatment of diseases caused by abnormality in a PRS (prolyl-tRNA synthetase) activity, a method for preparing the same, and a pharmaceutical composition comprising the same.